Abuse liability of diazepam through different routes

Indian Journal of Physiology and Pharmacology

Volumn 45, Issue 2, 2001, Pages 181-190

  Singh, R K L ^a   Jain, R ^a   Ray, R ^a   Gupta, Y K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Abuse liability; Diazepam; Routes of administration

Indexed keywords

DIAZEPAM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG USE; EUPHORIA; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SINGLE BLIND PROCEDURE;

ADULT; DIAZEPAM; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; SUBSTANCE-RELATED DISORDERS;

EID: 0034994082     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. A collaborative study on nacortic drug and psychotropic substances
2. Profile of a non-heroin injecting drug user. Case report
3. Pharmacokinetic considerations in abuse liability evaluation
4. Pharmacokinetic profile of diazepam in man following single intravenous oral chronic oral administrations
5. Methods for evaluating addiction liability. (A) Attitude of opiate addicts towards opiate like drugs. (B) A short term direct addiction test
6. The assessment of the abuse potentiality of sedative hypnotics (depressants): Methods used in animals and man
7. Development of the addiction research center inventory (ARCI): Selection of items that are sensitive to the effects of various drugs
8. Analytical methods
9. Rate of increase of plasma drug level influences subjective response in humans
10. Testing and abuse liability of anxiolytic and hypnotic drugs in humans
11. Diazepam metabolism in normal man: I-Serum concentrations and clinical effects after intravenous, intramuscular and oral administration
12. Relative abuse liability of diazepam and oxazepam: Behavioural and subjective does effects
13. Abuse liability assessment in human subjects
14. Delayed recovery levels of diazepam with clinical effects after oral and intravenous administration
15. Pharmacokinetics of distribution and metabolism of ataractic drugs and an evaluation of the site of antianxiey activity
16. Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-miphenytoin, but not debrisoqin, hydroxylation phenotype
17. Abuse liability of buprenorphine. A study among experienced drug users